Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism
Kelly Lambert, Emanuele Rinninella, Annabel Biruete, Keiichi Sumida, Jordan Stanford, Pauline Raoul, Maria Cristina Mele, Angela Yee‐Moon Wang, Denise Mafra
Abstract
There is increasing interest in the therapeutic potential of manipulating the gut microbiome of patients with chronic kidney disease (CKD). This is because there is a substantial deviation from a balanced gut microbiota profile in CKD, with many deleterious downstream effects. Nutritional interventions such as plant-based diets with reduced animal protein intake and the use of probiotics, prebiotics, and synbiotics may alter the microbiome. This article aims to briefly describe what is known about the gut microbiome in patients with CKD, factors contributing to gut dysbiosis, and outline important evidence gaps. Future potential therapies, including restoring the microbiota with food and microbiota-based and metabolomic-based therapies, are also discussed.